Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Tubal cancer screening

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.07.18
Views: 1236
Rating:

Adam Rosenthal - University College London Hospital, London, UK

Adam Rosenthal speaks with ecancer at BCGS 2018 about the fallopian origins of many high-grade serous ovarian cancers.

He describes rates of disease development in the UK, and the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) trial.

He also discusses early screening of women at a high risk due to detected genetic mutations known to be drivers of ovarian cancer, and subsequent surgery.

Read the Lancet paper discussed here.

Related videos

follow us

BGICC conference


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation